Clinical Trial Update: A Study of BGM0504 in Participants with Type 2 Diabetes [Phase 3]

View source ↗

Summary

This clinical trial update notes that BrightGene's BGM0504 is in Phase 3 testing for Type 2 diabetes mellitus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Status: RECRUITING